{
    "questions": [
        {
            "id": "643d41e757b1c7a315000037",
            "type": "list",
            "exact_answer": [
                [
                    "schizophrenia",
                    "syndrome",
                    "aggressive"
                ]
            ]
        },
        {
            "id": "64179139690f196b5100002f",
            "type": "list",
            "exact_answer": [
                [
                    "ck",
                    "mlpa"
                ]
            ]
        },
        {
            "id": "644289c457b1c7a31500005e",
            "type": "list",
            "exact_answer": [
                [
                    "periscapular",
                    "hip girdle weakness",
                    "hearing loss",
                    "foot dorsiflexor"
                ]
            ]
        },
        {
            "id": "641791ca690f196b51000031",
            "type": "list",
            "exact_answer": [
                [
                    "emery-dreifuss muscular dystrophy"
                ]
            ]
        },
        {
            "id": "644291fa57b1c7a31500005f",
            "type": "list",
            "exact_answer": [
                [
                    "1",
                    "dm type 1",
                    "type 1",
                    "type 2 (dm2) is considered less severe than dm type 1",
                    "dm type 2 (dm2) is considered less severe than dm type 1"
                ]
            ]
        },
        {
            "id": "63f741a633942b094c000009",
            "type": "list",
            "exact_answer": [
                [
                    "bristol",
                    "relatlimab",
                    "nivolumab",
                    "relatimab"
                ]
            ]
        },
        {
            "id": "64163568690f196b5100001b",
            "type": "list",
            "exact_answer": [
                [
                    "exons 3-9",
                    "exons 3",
                    "exons",
                    "exons 3-9 encompassing a mutational hot spot",
                    "exons 3-"
                ]
            ]
        },
        {
            "id": "6442869857b1c7a31500005d",
            "type": "list",
            "exact_answer": [
                [
                    "dna",
                    "dna test"
                ]
            ]
        },
        {
            "id": "641794e7690f196b51000036",
            "type": "list",
            "exact_answer": [
                [
                    "epilepsy",
                    "depression"
                ]
            ]
        },
        {
            "id": "63ee5c78f36125a426000001",
            "type": "list",
            "exact_answer": [
                [
                    "interleukin-4"
                ]
            ]
        },
        {
            "id": "64316f8e57b1c7a315000016",
            "type": "list",
            "exact_answer": [
                [
                    "chondrocytes",
                    "osteocytes"
                ]
            ]
        },
        {
            "id": "641c5201690f196b51000040",
            "type": "list",
            "exact_answer": [
                [
                    "multiple sclerosis",
                    "ris",
                    "chronic kidney disease",
                    "myotonic dystrophy type 1",
                    "lung cancer",
                    "amyotrophic lateral sclerosis",
                    "frontotemporal dementia"
                ]
            ]
        },
        {
            "id": "643c183b57b1c7a31500002c",
            "type": "list",
            "exact_answer": [
                [
                    "chip-seq",
                    "faire-seq",
                    "transposase",
                    "atac-seq",
                    "mnase-seq",
                    "damid",
                    "dnase-seq"
                ]
            ]
        },
        {
            "id": "64402f6f57b1c7a315000045",
            "type": "list",
            "exact_answer": [
                [
                    "1.8 or 9.0 g/day",
                    "1",
                    "1.8 or 9.0",
                    "1.8 or 9.0 g/day), or a matching dose of nondeuterated ethyl linoleate",
                    "1.8 or 9.0 g"
                ]
            ]
        },
        {
            "id": "6440f85c57b1c7a315000051",
            "type": "list",
            "exact_answer": [
                [
                    "nips"
                ]
            ]
        },
        {
            "id": "6402ba49201352f04a000004",
            "type": "list",
            "exact_answer": [
                [
                    "cobimetinib",
                    "vemurafenib",
                    "atezolizumab"
                ]
            ]
        },
        {
            "id": "641791b9690f196b51000030",
            "type": "list",
            "exact_answer": [
                [
                    "-related rigid",
                    "merosin-deficient",
                    "collagen vi-deficient"
                ]
            ]
        },
        {
            "id": "643d3e6157b1c7a315000034",
            "type": "list",
            "exact_answer": [
                [
                    "proanp",
                    "nt-probnp"
                ]
            ]
        }
    ]
}